Skip to main content
CDC Website

CDC Program/Policy

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) [Latent TB Infection Treatment]

Submitted by NPIN admin in on

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Sexually Transmitted Diseases Treatment Guidelines, 2015

Submitted by NPIN admin in on

This serial updates the 2010 clinical guidelines for treating STDs. These recommendations were developed by the CDC in consultation with professionals knowledgeable about the treatment of STDs.

Sexually Transmitted Diseases Summary of 2015 CDC Treatment Guidelines [Wall Chart]

Submitted by NPIN admin in on

This information sheet is meant to be a wall chart summary of CDC's 2015 STDs Treatment Guidelines. The chart has columns for disease, recommended Rx, dose/route, and alternatives. The STDs included in the chart are: bacterial vaginosis, cervicitis, chlamydial infections, epididymitis, genital herpes simplex, genital warts, gonococcal infections, lymphogranuloma venereum, nongonococcal urethritis, pediculosis pubis, pelvic inflammatory disease (PID), scabies, syphilis, and trichomoniasis.

Sexually Transmitted Diseases Summary of 2015 CDC Treatment Guidelines [Pocket Guide]

Submitted by NPIN admin in on

This pamphlet is a pocket guide for health professionals is a summary of CDC's 2015 STDs Treatment Guidelines. Each page discusses a disease, recommended Rx, dose/route, and alternatives. The STDs included in the chart are: bacterial vaginosis, cervicitis, chlamydial infections, epididymitis, genital herpes simplex, genital warts, gonococcal infections, lymphogranuloma venereum, nongonococcal urethritis, pediculosis pubis, pelvic inflammatory disease (PID), scabies, syphilis, and trichomoniasis.

STI Screening as HIV Prevention

Submitted by NPIN admin in on

In this video, Dr. Gail Bolan, Director of CDC's Division of STD Prevention, highlights the role of screening for sexually transmitted infections to help prevent HIV transmission.

National Hepatitis C Prevention Strategy

Submitted by NPIN admin in on

This comprehensive plan for health care professionals and policy makers addresses the prevention and control of hepatitis C virus (HCV) infection and its consequences. This strategy strives to protect the public's health by outlining guidelines for prevention and control of HCV infection, providing credible information on hepatitis C to enhance healthy decisions and promoting healthy living through strong partnerships with national, state, and local organizations in both the public and private sectors.

Recommendations for Public Health Surveillance of Syphilis in the United States

Submitted by NPIN admin in on

This monograph reports on updated syphilis surveillance guidelines for use in improving and developing syphilis surveillance techniques and making collection and reporting of syphilis surveillance data more uniform. The monograph discusses the purposes and uses of the two main components of syphilis surveillance: case reporting and prevalence monitoring. It also provides case definitions to be used for syphilis, reporting formats and intervals, and guidelines for provider-based and laboratory-based case reporting.

MMWR: Prevention and Control of Infections With Hepatitis Viruses in Correctional Settings

Submitted by NPIN admin in on

This report consolidates previous recommendations and adds new ones for preventing and controlling infections with hepatitis viruses among inmates and workers in correctional facilities. The recommendations provide guidelines for juvenile and adult correctional systems regarding (1) identification and investigation of acute viral hepatitis, (2) pre-exposure and postexposure immunization for hepatitis A and B, (3) prevention of hepatitis C virus infection and its consequences, (4) health education, and (5) release planning.